Risk of cardiac events with GnRH agonists but not antagonists

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-020-76748-2
中图分类号
学科分类号
摘要
引用
收藏
页码:11 / 11
相关论文
共 50 条
  • [41] Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: Analysis of real-life data from Eudra-Vigilance database
    De Nunzio, C.
    Cicione, A. F. M.
    Di Giacomo, F.
    Disabato, G.
    Nacchia, A.
    Gravina, C.
    Voglino, O. A.
    Franco, A.
    Lombardo, R.
    Rovesti, L.
    Baldassarri, V
    D'Annunzio, S.
    Turchi, B.
    Gallo, G.
    Stira, J.
    Guercio, A.
    Guarnotta, G.
    Tubaro, A.
    EUROPEAN UROLOGY, 2022, 81 : S316 - S317
  • [42] CARDIOVASCULAR ADVERSE EVENTS-RELATED TO GNRH AGONISTS AND GNRH ANTAGONISTS: ANALYSIS OF REAL-LIFE DATA FROM EUDRA-VIGILANCE DATABASE
    De Nunzio, Cosimo
    Nacchia, Antonio
    Cicione, Antonio
    Turchi, Beatrice
    Gallo, Giacomo
    Gravina, Carmen
    Guercio, Alessandro
    Stira, Jordi
    Rivesti, Lorenzo Maria
    Franco, Antonio
    Mancini, Elisa
    Voglino, Olivia Alessandra
    Baldassarri, Valeria
    Guarnotta, Giorgio
    Di Giacomo, Ferdinando
    Disabato, Giuseppe
    Tubaro, Andrea
    JOURNAL OF UROLOGY, 2022, 207 (05): : E825 - E825
  • [43] GnRH antagonists vs. GnRH agonists in poor ovarian responders: a meta-analysis
    Franco, J., Jr.
    Baruffi, R. L. R.
    Mauri, A. L.
    Petersen, C. G.
    Felipe, V.
    Oliveira, J. B. A.
    HUMAN REPRODUCTION, 2006, 21 : I3 - I4
  • [44] Einsatz von GnRH-Antagonisten vs. -AgonistenUse of GnRH antagonists versus agonists
    Jürgen Breul
    Der Urologe, 2016, 55 (9): : 1238 - 1239
  • [45] Follicular cohort of IVF patients treated with GnRH agonists or antagonists.
    Olivennes, FJ
    Lacroix, S
    Fanchin, R
    Righini, C
    Ledee, N
    Frydman, R
    FERTILITY AND STERILITY, 2001, 76 (03) : S174 - S175
  • [46] Suppressing reproductive activity in horses using GnRH vaccines, antagonists or agonists
    Stout, TAE
    Colenbrander, B
    ANIMAL REPRODUCTION SCIENCE, 2004, 82-3 : 633 - 643
  • [47] GNRH agonists versus antagonists: outcome of over 4000 ICSI cycles
    Tavmergen, E.
    Sahin, G.
    Akdogan, A.
    Levi, R.
    Goker, E. N. T.
    HUMAN REPRODUCTION, 2012, 27
  • [48] USE OF GNRH AGONISTS AND ANTAGONISTS FOR THE SUPPRESSION OF TESTICULAR FUNCTION IN MONKEYS AND MEN
    NIESCHLAG, E
    WEINBAUER, GF
    BEHRE, HM
    CONTRACEPTION, 1992, 46 (02) : 189 - 192
  • [49] Cardiovascular risk of androgen deprivation therapy for treatment of hormone-dependent prostate cancer. Differences between GnRH antagonists and GnRH agonists
    Tschoepe, C.
    Kherad, B.
    Spillmann, F.
    Schneider, C. A.
    Pieske, B.
    Krackhardt, F.
    HERZ, 2016, 41 (08) : 697 - 705
  • [50] Cardiovascular risk profiles of GnRH agonists and antagonists: real-world analysis from UK general practice
    Patrick Davey
    Mike G. Kirby
    World Journal of Urology, 2021, 39 : 307 - 315